|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.|
|US6696481||ADHERA||Salt of perindopril and pharmaceutical compositions containing it|| |
(5 months ago)
|US7846961||ADHERA||α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it|| |
(6 years from now)
Prestalia is owned by Adhera.
Prestalia contains Amlodipine Besylate; Perindopril Arginine.
Prestalia has a total of 2 drug patents out of which 1 drug patent has expired.
Expired drug patents of Prestalia are:
Prestalia was authorised for market use on 21 January, 2015.
Prestalia is available in tablet;oral dosage forms.
Prestalia can be used as treatment of hypertension.
The generics of Prestalia are possible to be released after 05 October, 2029.
Market Authorisation Date: 21 January, 2015
Treatment: Treatment of hypertension
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic